NL193907B - Basische ether en farmaceutische samenstelling die de basische ether als actief bestanddeel bevat. - Google Patents
Basische ether en farmaceutische samenstelling die de basische ether als actief bestanddeel bevat.Info
- Publication number
- NL193907B NL193907B NL8006722A NL8006722A NL193907B NL 193907 B NL193907 B NL 193907B NL 8006722 A NL8006722 A NL 8006722A NL 8006722 A NL8006722 A NL 8006722A NL 193907 B NL193907 B NL 193907B
- Authority
- NL
- Netherlands
- Prior art keywords
- basic ether
- pharmaceutical composition
- active ingredient
- composition containing
- ether
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU79EE2715A HU179164B (en) | 1979-12-14 | 1979-12-14 | Process for producing cycloalkyl-ethers of alkanolamines |
HUEE002715 | 1979-12-14 |
Publications (3)
Publication Number | Publication Date |
---|---|
NL8006722A NL8006722A (nl) | 1981-07-16 |
NL193907B true NL193907B (nl) | 2000-10-02 |
NL193907C NL193907C (nl) | 2001-02-05 |
Family
ID=10995882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL8006722A NL193907C (nl) | 1979-12-14 | 1980-12-11 | Basische ether en farmaceutische samenstelling die de basische ether als actief bestanddeel bevat. |
Country Status (27)
Country | Link |
---|---|
US (1) | US4342762A (nl) |
JP (1) | JPS56123953A (nl) |
AT (1) | AT374449B (nl) |
AU (1) | AU539173B2 (nl) |
BE (1) | BE886579A (nl) |
CA (1) | CA1155115A (nl) |
CH (1) | CH649986A5 (nl) |
CS (1) | CS216544B2 (nl) |
DD (1) | DD155320A5 (nl) |
DE (1) | DE3047142C2 (nl) |
DK (1) | DK156825C (nl) |
ES (1) | ES8200857A1 (nl) |
FI (1) | FI76783C (nl) |
FR (1) | FR2471968B1 (nl) |
GB (1) | GB2065122B (nl) |
GR (1) | GR72509B (nl) |
HU (1) | HU179164B (nl) |
IE (1) | IE51733B1 (nl) |
IL (1) | IL61685A (nl) |
IT (1) | IT1209377B (nl) |
NL (1) | NL193907C (nl) |
NO (1) | NO150638C (nl) |
PL (1) | PL127036B1 (nl) |
SE (1) | SE451132B (nl) |
SU (1) | SU1253425A3 (nl) |
UA (1) | UA5566A1 (nl) |
YU (1) | YU42367B (nl) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5212188A (en) * | 1992-03-02 | 1993-05-18 | R. J. Reynolds Tabacco Company | Method for treatment of neurodegenerative diseases |
US5242934A (en) * | 1992-03-02 | 1993-09-07 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
US5242935A (en) * | 1992-03-06 | 1993-09-07 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
US5227385A (en) * | 1992-03-13 | 1993-07-13 | Wake Forest University | Method for treatment of neurodegenerative diseases |
US5288872A (en) * | 1992-03-13 | 1994-02-22 | Wake Forest University | Compounds for treatment of neurodegenerative diseases |
US5214060A (en) * | 1992-04-10 | 1993-05-25 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
US5276043A (en) * | 1992-04-10 | 1994-01-04 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
US5187169A (en) * | 1992-04-10 | 1993-02-16 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
US5232932A (en) * | 1992-05-21 | 1993-08-03 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
US5248690A (en) * | 1992-07-07 | 1993-09-28 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
US5242916A (en) * | 1992-07-07 | 1993-09-07 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
JPH0626170A (ja) * | 1992-07-09 | 1994-02-01 | Yodogawa Steel Works Ltd | 壁板材の取付構造 |
JPH06193226A (ja) * | 1992-12-26 | 1994-07-12 | Yodogawa Steel Works Ltd | 壁板材の取付構造 |
HU214588B (hu) * | 1994-07-01 | 1998-04-28 | EGIS Gyógyszergyár Rt. | Eljárás bicikloheptán-származékot tartalmazó, CCK-rendszer gátló hatású gyógyászati készítmények előállítására |
KR100381558B1 (ko) * | 1994-07-01 | 2003-08-19 | 에지스 지오기스제르기아르 알티. | 약제조성물및이의제조방법 |
US5652270A (en) * | 1994-07-01 | 1997-07-29 | Egis Gyogyszergyar Rt | Pharmaceutical compositions containing bicycloheptane ether amines and a process for the preparation thereof |
US5583140A (en) * | 1995-05-17 | 1996-12-10 | Bencherif; Merouane | Pharmaceutical compositions for the treatment of central nervous system disorders |
HU226061B1 (en) * | 1996-10-17 | 2008-04-28 | Egis Gyogyszergyar Nyilvanosan | 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation |
HUP9900445A2 (hu) * | 1999-02-24 | 2001-06-28 | EGIS Gyógyszergyár Rt. | Eljárás (1R,2S,4R)-(-)-N,N-(dimetilamino-etoxi)-2-fenil-1,7,7-trimetil-biciklo[2.2.1]heptán előállítására és ennek köztiterméke |
HU227114B1 (en) * | 1999-05-11 | 2010-07-28 | Egis Gyogyszergyar Nyilvanosan | (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same |
FI20002612A0 (fi) * | 2000-11-28 | 2000-11-28 | Orion Yhtymae Oyj | Yhdistelmäterapia serotoniinivälityksen häiriöiden hoitamiseksi |
US6335372B1 (en) * | 2000-11-28 | 2002-01-01 | Orion Corporation | Treatment of obsessive compulsive disorder |
HUP0103017A3 (en) * | 2001-07-18 | 2004-05-28 | Egis Gyogyszergyar Nyilvanosan | Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use |
GB0306604D0 (en) * | 2003-03-21 | 2003-04-30 | Curidium Ltd | Second medical use |
US20040192754A1 (en) * | 2003-03-24 | 2004-09-30 | Shapira Nathan Andrew | Methods for treating idiopathic hyperhidrosis and associated conditions |
HUP0301537A3 (en) * | 2003-06-03 | 2005-07-28 | Egis Gyogyszergyar Nyilvanosan | Deramcyclane fumarate tablets and process for producing them |
KR101493508B1 (ko) * | 2013-02-18 | 2015-02-16 | 오스템임플란트 주식회사 | 치아 미백 조성물 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE581863A (nl) * | 1959-08-06 | |||
DE1108684B (de) * | 1960-01-29 | 1961-06-15 | Boehringer & Soehne Gmbh | Verfahren zur Herstellung neuer basischer AEther |
GB895050A (en) * | 1960-01-29 | 1962-04-26 | Boehringer & Soehne Gmbh | New basic ethers |
AT264495B (de) * | 1963-08-18 | 1968-09-10 | Egyt Gyogyszervegyeszeti Gyar | Verfahren zur Herstellung von neuen basischen Cycloheptanoläthern |
GB1085969A (en) * | 1965-08-11 | 1967-10-04 | Glidden Co | Insectiphobic compositions comprising terpene derivatives |
US4118499A (en) * | 1975-10-15 | 1978-10-03 | Glaxo Laboratories Limited | Anti-anxiety and anti-parkinsonian 1-aminoalkyl-2-endo-chloro-7,7-dimethylnorbornanes |
JPS6034925B2 (ja) * | 1979-07-31 | 1985-08-12 | 帝人株式会社 | 持続性鼻腔用製剤およびその製造法 |
-
1979
- 1979-12-14 HU HU79EE2715A patent/HU179164B/hu unknown
-
1980
- 1980-12-09 GB GB8039376A patent/GB2065122B/en not_active Expired
- 1980-12-10 YU YU3111/80A patent/YU42367B/xx unknown
- 1980-12-10 BE BE1/10069A patent/BE886579A/fr not_active IP Right Cessation
- 1980-12-10 IL IL61685A patent/IL61685A/xx not_active IP Right Cessation
- 1980-12-10 SE SE8008680A patent/SE451132B/sv not_active IP Right Cessation
- 1980-12-11 US US06/215,154 patent/US4342762A/en not_active Expired - Lifetime
- 1980-12-11 CS CS808736A patent/CS216544B2/cs unknown
- 1980-12-11 DK DK528980A patent/DK156825C/da not_active IP Right Cessation
- 1980-12-11 FR FR8026269A patent/FR2471968B1/fr not_active Expired
- 1980-12-11 PL PL1980228392A patent/PL127036B1/pl unknown
- 1980-12-11 CH CH9133/80A patent/CH649986A5/de not_active IP Right Cessation
- 1980-12-11 AT AT0601380A patent/AT374449B/de not_active IP Right Cessation
- 1980-12-11 FI FI803858A patent/FI76783C/fi not_active IP Right Cessation
- 1980-12-11 JP JP17520880A patent/JPS56123953A/ja active Granted
- 1980-12-11 NL NL8006722A patent/NL193907C/nl not_active IP Right Cessation
- 1980-12-11 AU AU65293/80A patent/AU539173B2/en not_active Expired
- 1980-12-11 DD DD80225942A patent/DD155320A5/de not_active IP Right Cessation
- 1980-12-12 IT IT8026587A patent/IT1209377B/it active
- 1980-12-12 SU SU3219704A patent/SU1253425A3/ru active
- 1980-12-12 UA UA3219704A patent/UA5566A1/uk unknown
- 1980-12-12 GR GR63641A patent/GR72509B/el unknown
- 1980-12-12 ES ES497717A patent/ES8200857A1/es not_active Expired
- 1980-12-12 CA CA000366719A patent/CA1155115A/en not_active Expired
- 1980-12-12 NO NO803764A patent/NO150638C/no not_active IP Right Cessation
- 1980-12-12 IE IE2612/80A patent/IE51733B1/en not_active IP Right Cessation
- 1980-12-15 DE DE3047142A patent/DE3047142C2/de not_active Expired
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL193907B (nl) | Basische ether en farmaceutische samenstelling die de basische ether als actief bestanddeel bevat. | |
NO801863L (no) | Farmasoeytiske preparater. | |
IT7928464A0 (it) | Composizione farmaceutica avente attivita' antitumorale. | |
NL980035I2 (nl) | Benzimidazolen, de bereiding daarvan en deze verbindingen bevattende geneesmiddelen. | |
IT8921118A0 (it) | Composizione per aerosol comprendente nitroglicerina come ingrediente attivo. | |
NL190664B (nl) | Gesubstitueerde benzhydrylpiperidinoderivaten met therapeutische werking en farmaceutische preparaten die deze verbindingen bevatten. | |
NO802378L (no) | Deodorant. | |
FI904444A0 (fi) | Aktiva limkompositioner. | |
NO802379L (no) | Deodorant. | |
IT1190824B (it) | Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo | |
NL990010I1 (nl) | Ä3HÜ-imidazo-Ä5,1-dÜ-1,2,3,5-tetrazine-4-on derivaten en farmaceutische samenstellingen, die deze derivaten bevatten. | |
IT1126406B (it) | 1,2,4,5-tetra-alchil-4-arilpiperidine e relative formulazioni farmaceutiche | |
NL7711446A (nl) | Pharmaceutische desinfecterend preparaat. | |
IT7926662A0 (it) | Composizione farmaceutica contenente 3,4-di-idro-3-osso-2-chinossaline. | |
IT7821686A0 (it) | Composizione farmaceutica. | |
NL188645C (nl) | 1-azaxanthon-3-carbonzuurverbindingen en farmaceutische preparaten die deze verbindingen bevatten. | |
DE3575073D1 (de) | Persimonensaft als wirkstoff enthaltendes deodorant. | |
IT8023208A0 (it) | Eteri ossimici, loro preparazione e composizioni farmaceutiche che licontengono. | |
IT1134039B (it) | Composizione farmaceutica ad azione prolungata | |
IT1228125B (it) | Materiali per profumi. | |
NL7902993A (nl) | Nieuwe isochinolinederivaten, de bereiding ervan en farmaceutische preparaten, die de nieuwe isochinoline- derivaten bevatten. | |
IT8019430A0 (it) | Formulazione farmaceutica a cessione protratta. | |
ATE36455T1 (de) | Pharmazeutische zusammensetzungen. | |
IT8020295A0 (it) | Composizione insetticida e acaricida. | |
NL7711777A (nl) | Biologisch actieve tricyclische verbindingen en farmaceutische samenstellingen, welke deze verbindingen als actief bestanddeel bevatten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A85 | Still pending on 85-01-01 | ||
BA | A request for search or an international-type search has been filed | ||
BB | A search report has been drawn up | ||
BC | A request for examination has been filed | ||
BT | A notification was added to the application dossier and made available to the public | ||
V4 | Discontinued because of reaching the maximum lifetime of a patent |
Free format text: 20010205 |